CN115400203A - 肾干细胞生长因子在制备改善或修复肾功能的产品中的用途 - Google Patents
肾干细胞生长因子在制备改善或修复肾功能的产品中的用途 Download PDFInfo
- Publication number
- CN115400203A CN115400203A CN202110580645.7A CN202110580645A CN115400203A CN 115400203 A CN115400203 A CN 115400203A CN 202110580645 A CN202110580645 A CN 202110580645A CN 115400203 A CN115400203 A CN 115400203A
- Authority
- CN
- China
- Prior art keywords
- solution
- stem cell
- sodium hyaluronate
- growth factor
- cell growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 102100032528 C-type lectin domain family 11 member A Human genes 0.000 title claims abstract description 36
- 101710167766 C-type lectin domain family 11 member A Proteins 0.000 title claims abstract description 36
- 230000003907 kidney function Effects 0.000 title claims abstract description 33
- 210000003734 kidney Anatomy 0.000 title claims abstract description 17
- 239000000243 solution Substances 0.000 claims description 69
- 239000000499 gel Substances 0.000 claims description 45
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 40
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 40
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 31
- 238000003756 stirring Methods 0.000 claims description 25
- 230000008569 process Effects 0.000 claims description 19
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims description 15
- 229920002125 Sokalan® Polymers 0.000 claims description 15
- 229960001631 carbomer Drugs 0.000 claims description 15
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims description 14
- 229940067606 lecithin Drugs 0.000 claims description 14
- 235000010445 lecithin Nutrition 0.000 claims description 14
- 239000000787 lecithin Substances 0.000 claims description 14
- 239000002502 liposome Substances 0.000 claims description 14
- 238000002360 preparation method Methods 0.000 claims description 14
- 239000003755 preservative agent Substances 0.000 claims description 14
- 230000002335 preservative effect Effects 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 11
- 210000000130 stem cell Anatomy 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 6
- 210000002700 urine Anatomy 0.000 claims description 6
- 238000005303 weighing Methods 0.000 claims description 5
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical group CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 4
- 230000003472 neutralizing effect Effects 0.000 claims description 4
- -1 small molecule sodium hyaluronate Chemical class 0.000 claims description 4
- 230000002485 urinary effect Effects 0.000 claims description 4
- 238000004113 cell culture Methods 0.000 claims description 3
- 210000002993 trophoblast Anatomy 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 239000000443 aerosol Substances 0.000 claims description 2
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000002417 nutraceutical Substances 0.000 claims description 2
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 2
- 239000011505 plaster Substances 0.000 claims description 2
- 239000000843 powder Substances 0.000 claims description 2
- 230000000699 topical effect Effects 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims 1
- 241000282414 Homo sapiens Species 0.000 abstract description 7
- 230000008439 repair process Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 2
- 230000036541 health Effects 0.000 abstract description 2
- 230000036299 sexual function Effects 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 11
- 230000000694 effects Effects 0.000 description 5
- 238000012360 testing method Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000902 placebo Substances 0.000 description 2
- 229940068196 placebo Drugs 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000003238 somatosensory effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229910021642 ultra pure water Inorganic materials 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (12)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110580645.7A CN115400203A (zh) | 2021-05-26 | 2021-05-26 | 肾干细胞生长因子在制备改善或修复肾功能的产品中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110580645.7A CN115400203A (zh) | 2021-05-26 | 2021-05-26 | 肾干细胞生长因子在制备改善或修复肾功能的产品中的用途 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115400203A true CN115400203A (zh) | 2022-11-29 |
Family
ID=84155560
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110580645.7A Pending CN115400203A (zh) | 2021-05-26 | 2021-05-26 | 肾干细胞生长因子在制备改善或修复肾功能的产品中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115400203A (zh) |
-
2021
- 2021-05-26 CN CN202110580645.7A patent/CN115400203A/zh active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20220409513A1 (en) | Cosmetic composition for peel-off-type packs, and method for producing same | |
CN112472660B (zh) | 一种含有壬二酸的微针贴片及其制备方法 | |
JPH0977687A (ja) | 調合薬の基剤、その製造方法、調合薬組成物、薬剤、医療材料及び化粧製品 | |
EP0109993B1 (en) | Method for extracting propolis and water soluble dry propolis powder obtained thereby and cosmetic and pharmaceutical preparations containing same | |
CN112022895B (zh) | 一种用于皮肤屏障修复的组合物及其制备方法 | |
CN113056257A (zh) | 应用于组织修复的含有吡非尼酮的半固体的基于油的药物组合物 | |
JP4366527B2 (ja) | 特に眼科分野における適用のための外傷および損傷の治癒および/または修復のための治療に適したアミノ酸組成物 | |
CN112315883B (zh) | 控油祛痘的护肤组合物及其制剂和应用 | |
WO2004067012A1 (fr) | Liposomes contenant de l'asiaticoside et leurs utilisations | |
JP2008105984A (ja) | コラーゲン産生促進剤、皮膚外用剤、浴用剤及び飲食物 | |
JP3577146B2 (ja) | 外用剤組成物 | |
CN115400203A (zh) | 肾干细胞生长因子在制备改善或修复肾功能的产品中的用途 | |
CN108653304A (zh) | 一种紫檀芪纳米胶束外用凝胶及其制备方法 | |
CN110193017B (zh) | 一种促毛发生长的喷膜剂及其制备方法 | |
CN110755310B (zh) | 促进皮肤微循环的活性组合物及其制备方法与应用 | |
JP3827259B2 (ja) | 表皮角質化促進剤 | |
CN112870127A (zh) | 富含人参精华的修护敏感肌肤草本组合物及其制备方法 | |
JPH05194214A (ja) | 創傷治癒促進剤 | |
EP2771013B1 (en) | Topical pharmaceutical compositions comprising acyclovir and hyaluronic acid | |
CN115068407A (zh) | 一种巴瑞克替尼凝胶剂及其制备方法与用途 | |
WO2019233158A1 (zh) | 中药凝胶组合物及其制备方法和用途 | |
CN112675228B (zh) | 一种促进伤口愈合的软膏剂及其制备方法 | |
CN114504549B (zh) | 生物素的水性凝胶剂及其制备方法和应用 | |
CN113713000B (zh) | 用于治疗疮痈、烧烫伤和痤疮的主药成分组合物、缓控释药物制剂及其制备方法和应用 | |
RU2506944C1 (ru) | Способ повышения трансдермальной проницаемости лечебных или косметических препаратов для наружного применения, способ введения в кожу газообразного ксенона |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230113 Address after: Room 818-033, Building 1, Yard 3, Jinhang East Road, Shunyi District, Beijing, 101300 (Tianzhu Comprehensive Bonded Zone) Applicant after: Beizhong Chuangke Biotechnology (Beijing) Co.,Ltd. Applicant after: REGEND THERAPEUTICS Co.,Ltd. Address before: 310056 Room 109, 1st Floor, Building 2, No. 658, Bin'an Road, Changhe Street, Binjiang District, Hangzhou City, Zhejiang Province Applicant before: Youjia Xinxuan Medical Technology (Hangzhou) Co.,Ltd. Applicant before: REGEND THERAPEUTICS Co.,Ltd. |
|
TA01 | Transfer of patent application right |